Summary by Moomoo AI
Trifolium Biopharmaceutical Co., Ltd. held its annual shareholder meeting on June 20, 2024, and voted on multiple resolutions. All resolutions were overwhelmingly passed, including the adoption of the audited comprehensive financial statements and board of directors and auditor's report for the year ended December 31, 2023, re-election of Dr. Liang Peng and two other directors, authorizing the board of directors to determine director remuneration, reappointing Ernst & Young as the auditor, and granting general authority to the directors to issue and repurchase shares. In addition, the revised outlines and regulations of the company's articles of association as presented in the special resolution were also approved. On the day of the annual shareholder meeting, there were 1,297,047,429 issued shares and 1,237,381,403 voting shares. Except for four directors who were absent due to official business, all other directors participated in the meeting either in person or through electronic means. The meeting was supervised by Hong Kong Central Clearing and Settlement System Limited.
